110 related articles for article (PubMed ID: 30095910)
21. Wnt signalling and the actin cytoskeleton.
Akiyama T; Kawasaki Y
Oncogene; 2006 Dec; 25(57):7538-44. PubMed ID: 17143298
[TBL] [Abstract][Full Text] [Related]
22. The miR-1-NOTCH3-Asef pathway is important for colorectal tumor cell migration.
Furukawa S; Kawasaki Y; Miyamoto M; Hiyoshi M; Kitayama J; Akiyama T
PLoS One; 2013; 8(11):e80609. PubMed ID: 24244701
[TBL] [Abstract][Full Text] [Related]
23. Asef2 and Neurabin2 cooperatively regulate actin cytoskeletal organization and are involved in HGF-induced cell migration.
Sagara M; Kawasaki Y; Iemura SI; Natsume T; Takai Y; Akiyama T
Oncogene; 2009 Mar; 28(10):1357-65. PubMed ID: 19151759
[TBL] [Abstract][Full Text] [Related]
24. Association of Asef and Cdc42 expression to tubular injury in diseased human kidney.
Cheng HT; Juang IP; Chen LC; Lin LY; Chao CH
J Investig Med; 2013 Oct; 61(7):1097-103. PubMed ID: 23941980
[TBL] [Abstract][Full Text] [Related]
25. Tumor-associated NH2-terminal fragments are the most stable part of the adenomatous polyposis coli protein and can be regulated by interactions with COOH-terminal domains.
Li Z; Näthke IS
Cancer Res; 2005 Jun; 65(12):5195-204. PubMed ID: 15958564
[TBL] [Abstract][Full Text] [Related]
26. Identification of ICAT as an APC Inhibitor, Revealing Wnt-Dependent Inhibition of APC-Axin Interaction.
Ji L; Lu B; Wang Z; Yang Z; Reece-Hoyes J; Russ C; Xu W; Cong F
Mol Cell; 2018 Oct; 72(1):37-47.e4. PubMed ID: 30197296
[TBL] [Abstract][Full Text] [Related]
27. Asef2 functions as a Cdc42 exchange factor and is stimulated by the release of an autoinhibitory module from a concealed C-terminal activation element.
Hamann MJ; Lubking CM; Luchini DN; Billadeau DD
Mol Cell Biol; 2007 Feb; 27(4):1380-93. PubMed ID: 17145773
[TBL] [Abstract][Full Text] [Related]
28. A neoepitope derived from a novel human germline APC gene mutation in familial adenomatous polyposis shows selective immunogenicity.
Majumder S; Shah R; Elias J; Mistry Y; Coral K; Shah P; Maurya AK; Mittal B; D'Silva JK; Murugan S; Mahadevan L; Sathian R; Ramprasad VL; Chakraborty P; Gupta R; Chaudhuri A; Khanna-Gupta A
PLoS One; 2018; 13(9):e0203845. PubMed ID: 30256815
[TBL] [Abstract][Full Text] [Related]
29. PH domain-mediated membrane targeting of Asef.
Muroya K; Kawasaki Y; Hayashi T; Ohwada S; Akiyama T
Biochem Biophys Res Commun; 2007 Mar; 355(1):85-8. PubMed ID: 17292853
[TBL] [Abstract][Full Text] [Related]
30. Adenomatous Polyposis Coli Defines Treg Differentiation and Anti-inflammatory Function through Microtubule-Mediated NFAT Localization.
Agüera-González S; Burton OT; Vázquez-Chávez E; Cuche C; Herit F; Bouchet J; Lasserre R; Del Río-Iñiguez I; Di Bartolo V; Alcover A
Cell Rep; 2017 Oct; 21(1):181-194. PubMed ID: 28978472
[TBL] [Abstract][Full Text] [Related]
31. [Familial adenomatous polyposis syndrome (FAP): pathogenesis and molecular mechanisms].
Friedrich A; Kullmann F
Med Klin (Munich); 2003 Dec; 98(12):776-82. PubMed ID: 14685680
[TBL] [Abstract][Full Text] [Related]
32. Asef is a Cdc42-specific guanine nucleotide exchange factor.
Gotthardt K; Ahmadian MR
Biol Chem; 2007 Jan; 388(1):67-71. PubMed ID: 17214551
[TBL] [Abstract][Full Text] [Related]
33. Involvement of adenomatous polyposis coli in colorectal tumorigenesis.
Jaiswal AS; Balusu R; Narayan S
Front Biosci; 2005 May; 10():1118-34. PubMed ID: 15769611
[TBL] [Abstract][Full Text] [Related]
34. Association and regulation of casein kinase 2 activity by adenomatous polyposis coli protein.
Homma MK; Li D; Krebs EG; Yuasa Y; Homma Y
Proc Natl Acad Sci U S A; 2002 Apr; 99(9):5959-64. PubMed ID: 11972058
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanisms of beta-catenin recognition by adenomatous polyposis coli revealed by the structure of an APC-beta-catenin complex.
Eklof Spink K; Fridman SG; Weis WI
EMBO J; 2001 Nov; 20(22):6203-12. PubMed ID: 11707392
[TBL] [Abstract][Full Text] [Related]
36. The APC protein binds to A/T rich DNA sequences.
Deka J; Herter P; Sprenger-Haussels M; Koosch S; Franz D; Müller KM; Kuhnen C; Hoffmann I; Müller O
Oncogene; 1999 Oct; 18(41):5654-61. PubMed ID: 10523845
[TBL] [Abstract][Full Text] [Related]
37. miR-155 Is Downregulated in Familial Adenomatous Polyposis and Modulates WNT Signaling by Targeting AXIN1 and TCF4.
Prossomariti A; Piazzi G; D'Angelo L; Miccoli S; Turchetti D; Alquati C; Montagna C; Bazzoli F; Ricciardiello L
Mol Cancer Res; 2018 Dec; 16(12):1965-1976. PubMed ID: 30072583
[TBL] [Abstract][Full Text] [Related]
38. Adenomatous polyposis coli determines sensitivity to histone deacetylase inhibitor-induced apoptosis in colon cancer cells.
Huang X; Guo B
Cancer Res; 2006 Sep; 66(18):9245-51. PubMed ID: 16982769
[TBL] [Abstract][Full Text] [Related]
39. Interaction between Ku80 protein and a widely used antibody to adenomatous polyposis coli.
Roberts GT; Davies ML; Wakeman JA
Br J Cancer; 2003 Jan; 88(2):202-5. PubMed ID: 12610503
[TBL] [Abstract][Full Text] [Related]
40. Adenomatous polyposis coli determines sensitivity to the EGFR tyrosine kinase inhibitor gefitinib in colorectal cancer cells.
Zhang Y; Xiao Q; Zhang H; Sun X; Ge H; Liu X; Guan L; Sun M
Oncol Rep; 2014 Apr; 31(4):1811-7. PubMed ID: 24573033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
